Ten Capital Wealth Advisors, LLC Protalix Bio Therapeutics, Inc. Transaction History

Ten Capital Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$1.0 - $1.37 $110 - $150	110 Added 12.36%	1,000 $1,000
Q3 2022 Nov 09, 2022	BUY	$1.03 - $1.24 $103 - $124	100 Added 12.66%	890 $1,000
Q1 2022 May 09, 2022	BUY	$0.81 - $1.17 $113 - $163	140 Added 21.54%	790 $1,000
Q4 2021 Jan 28, 2022	BUY	$0.81 - $1.33 $79 - $130	98 Added 17.75%	650 $1,000
Q3 2021 Nov 12, 2021	BUY	$1.31 - $1.87 $297 - $424	227 Added 69.85%	552 $1,000
Q2 2021 Aug 12, 2021	BUY	$1.86 - $6.22 $232 - $777	125 Added 62.5%	325 $1,000
Q1 2021 May 13, 2021	BUY	$3.58 - $6.45 $716 - $1,290	200 New	200 $0

5.61M

103K

4.6K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $53.7M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Ten Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ten Capital Wealth Advisors, LLC with notifications on news.